Autocrine IL-2-dependent Growth of a Newly Established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− Leukemia Cell Line (NOI-90)

Leukemia - United Kingdom
doi 10.1038/sj.leu.2400562
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P62: Evaluation of Natural Killer Cell Markers CD16, CD56, and CD57 in the Endometrium of Women With Recurrent Pregnancy Loss

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

The Expression of BORIS Protein in a Newly Established Primary Glioma Cell Culture Line

2011English

High Level EGFR Amplification in a Newly Established Glioblastoma Cell Line 170-Mg-Ba

Neoplasma
Cancer Research
2019English

A Human Thyroid Cancer Cell Line, DH-14-3, Newly Established From Poorly Differentiated Thyroid Carcinoma

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Development of Engineered T Cells Expressing a Chimeric CD16-CD3 Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2016English

OR19: Decidual Stromal Cells Promote the Differentiation of CD56 Bright CD16 − NK Cells by Secreting IL‐24 in Early Pregnancy

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

Epidermal Growth Factor Stimulates the Cell Growth of the PA-1 Teratocarcinoma Cell Line in an Autocrine/Paracrine Fashion

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1995English

IL-2: More Than a T Cell Growth Factor

Journal of Immunology
AllergyImmunology
2007English

CD56+ CD7+ Stem Cell Leukemia/Lymphoma With D2-J.DELTA.1 Rearrangement.

Internal Medicine
Internal MedicineMedicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy